The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Clayman Michael D. since 2015.
The trader's CIK number is 1597407.
At the time of the last reporting, Clayman Michael D. was the President and CEO of Flexion Therapeutics Inc. (stock ticker symbol FLXN).
Also see all insider trading activities at Flexion Therapeutics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | FLXN | 10,256 | $99,996 | 0 | $0 | 0 | $0 |
| 2019 | FLXN | 10,375 | $125,210 | 3,278 | $40,516 | 14,800 | $0 |
| 2018 | FLXN | 15,000 | $308,774 | 0 | $0 | 14,800 | $0 |
| 2017 | FLXN | 10,000 | $204,150 | 0 | $0 | 14,800 | $0 |
| 2016 | FLXN | 14,999 | $189,480 | 0 | $0 | 10,369 | $1,690 |
| 2015 | FLXN | 0 | $0 | 0 | $0 | 5,000 | $815 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-05-26 | FLXN | Buy | 10,256 | 9.75 | 99,996 |
| 2019-10-06 | FLXN | Option Ex | 14,800 | .00 | 0 |
| 2019-08-08 | FLXN | Buy | 2,317 | 10.85 | 25,137 |
| 2019-05-10 | FLXN | Buy | 4,012 | 12.48 | 50,065 |
| 2019-03-12 | FLXN | Buy | 4,046 | 12.36 | 50,008 |
| 2019-01-03 | FLXN | Sale | 3,278 | 12.36 | 40,516 |
| 2018-11-09 | FLXN | Buy | 5,000 | 17.09 | 85,475 |
| 2018-10-08 | FLXN | Option Ex | 14,800 | .00 | 0 |
| 2018-08-09 | FLXN | Buy | 10,000 | 22.33 | 223,299 |
| 2017-11-08 | FLXN | Buy | 5,000 | 23.60 | 118,000 |
| 2017-10-06 | FLXN | Option Ex | 14,800 | .00 | 0 |
| 2017-06-05 | FLXN | Buy | 5,000 | 17.23 | 86,150 |
| 2016-11-23 | FLXN | Buy | 1,667 | 18.41 | 30,687 |
| 2016-11-22 | FLXN | Buy | 1,666 | 17.95 | 29,899 |
| 2016-11-21 | FLXN | Buy | 1,666 | 17.90 | 29,828 |
| 2016-05-23 | FLXN | Option Ex | 10,369 | .16 | 1,690 |
| 2016-05-20 | FLXN | Buy | 2,000 | 10.40 | 20,810 |
| 2016-05-19 | FLXN | Buy | 2,000 | 9.65 | 19,298 |
| 2016-05-18 | FLXN | Buy | 2,000 | 10.23 | 20,466 |
| 2016-05-17 | FLXN | Buy | 2,000 | 9.73 | 19,466 |
| 2016-05-16 | FLXN | Buy | 2,000 | 9.51 | 19,026 |
| 2015-03-24 | FLXN | Option Ex | 5,000 | .16 | 815 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Clayman Michael D. (President and CEO of Flexion Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.